Cancer incidence following expansion of HIV treatment in Botswana

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Dryden Peterson, Scott ^a,b,c,d   Medhin, Heluf ^e   Kebabonye Pusoentsi, Malebogo ^e   Seage, George R ^c   Suneja, Gita ^f   Kayembe, Mukendi K A ^e   Mmalane, Mompati ^b   Rebbeck, Timothy ^g   Rider, Jennifer R ^c   Essex, Myron ^c   Lockman, Shahin ^a,b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Department of HIV AIDS Prevention and Care   (Botswana)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BLOOD EXAMINATION; BOTSWANA; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONJUNCTIVA TUMOR; CONTROLLED STUDY; CYTODIAGNOSIS; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; PROSTATE CANCER; TREND STUDY; UTERINE CERVIX CANCER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; INCIDENCE; NEOPLASMS;

ANTINEOPLASTIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BOTSWANA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS;

EID: 84942871006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135602     Document Type: Article

References (30)

1. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014; 384 (9939):241-8. doi: 10.1016/S0140-6736(14)60604-8 PMID: 25042234.
2. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids. 2006; 20(12):1645-54. Epub 2006/07/27. doi: 10.1097/01.aids.0000238411.75324.59 00002030-200608010-00010 [pii]. PMID: 16868446.
3. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011; 103(9):753-62. doi: 10.1093/jnci/djr076 PMID: 21483021; PubMed Central PMCID: PMC3086877.
4. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIVinfected individuals. J Acquir Immune Defic Syndr. 2009; 52(5):611-22. Epub 2009/09/23. doi: 10.1097/QAI.0b013e3181b327ca PMID: 19770804; PubMed Central PMCID: PMC2790038.
5. Martin J, Wenger M, Busakhala N, Buziba N, Bwana M, Muyindike W, et al. Prospective Evaluation of the Impact of ART on the Incidence of KS - IeDEA Consortium: East Africa. 19th Conference on Retroviruses and Opportunistic Infections; Seattle2012.
6. Mutyaba I, Phipps W, Krantz EM, Goldman JD, Nambooze S, Orem J, et al. A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008. J Acquir Immune Defic Syndr. 2015. doi: 10.1097/QAI.0000000000000620 PMID: 25844696.
7. Msyamboza KP, Dzamalala C, Mdokwe C, Kamiza S, Lemerani M, Dzowela T, et al. Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry. BMC research notes. 2012; 5:149. doi: 10.1186/1756-0500-5-149 PMID: 22424105; PubMed Central PMCID: PMC3327635.
8. Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment. Int J Epidemiol. 2006. Epub 2006/07/21. doi: dyl098 [pii] doi: 10.1093/ije/dyl098
9. National AIDS Coordinating Agency. Botswana AIDS Impact Survey IV: Stats Brief. Gaborone, Botswana: Central Statistics Office, 2013.
10. National AIDS Coordinating Agency. Progress Report of the National Response to the 2001 Declaration of Commitment on HIV and AIDS: Botswana Country Report 2010. Gaborone, Botswana: Botswana National AIDS Coordinating Agency, Joint United Programme on HIV/AIDS, 2010.
11. Ramogola-Masire D. Cervical Cancer, HIV, and the HPV Vaccine in Botswana. In: Wailoo K, Livingston J, Epstein S, Aronowitz R, editors. Three Shots at Prevention: The HPV Vaccine and the Politics of Medicine's Simple Solutions. Baltimore: Johns Hopkins University Press; 2010.
12. National AIDS Coordinating Agency. Botswana AIDS Impact Survey II: Statistical Report. Gaborone, Botswana: Central Statistics Office, 2004.
13. National AIDS Coordinating Agency. Botswana AIDS Impact Survey III: Popular Report. Gaborone, Botswana: Central Statistics Office, 2008.
14. Central Statistics Office. 2006 Population and Housing Census. 2006.
15. Ministry of Health. Botswana Guidelines on Antiretroviral Treatment. 2002.
16. Ministry of Health. Botswana Guidelines on Antiretroviral Treatment. 2005.
17. Ministry of Health. National Cervical Cancer Prevention Programme: Five-Year Comprehensive Control Strategy (2012-2016). 2012.
18. Suneja G, Ramogola-Masire D, Medhin HG, Dryden-Peterson S, Bekelman JE. Cancer in Botswana: resources and opportunities. Lancet Oncol. 2013; 14(8):e290-1. doi: 10.1016/S1470-2045(13)70283-3 PMID: 23816293.
19. Parkin DM. Findings and recommendations for the Botswana National Cancer Registry, International Agency for Research on Cancer. 2013.
20. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer. 2009; 45(5):756-64. doi: 10.1016/j.ejca.2008.11.033 PMID: 19128954.
21. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. European journal of cancer. 2009; 45(5):747-55. doi: 10.1016/j.ejca.2008.11.032 PMID: 19117750.
22. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014; 23(6):953-66. doi: 10.1158/1055-9965.EPI-14-0281 PMID: 24700176.
23. International Union against Cancer., International Agency for Research on Cancer., International Association of Cancer Registries. Cancer incidence in five continents. Vol 3-: IARC scientific publications. Berlin; New York: Distributed for the Union by Springer-Verlag; 1966. p. v.
24. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004; 15(5):615-25. PMID: 15308962.
25. Naimi AI, Moodie EE, Auger N, Kaufman JS. Constructing inverse probability weights for continuous exposures: a comparison of methods. Epidemiology. 2014; 25(2):292-9. doi: 10.1097/EDE.0000000000000053 PMID: 24487212.
26. Dryden-Peterson S, Medhin H, Iwe N, Pusoentsi M, Avalos A, LaCasce A, et al. Malignancies among HIV+ and HIV-patients in a prospective cohort: Botswana. 19th Conference on Retroviruses and Opportunistic Infections (CROI); 5-8 Mar 2012; Seattle, WA2012.
27. Wester CW, Bussmann H, Moyo S, Avalos A, Gaolathe T, Ndwapi N, et al. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clin Infect Dis. 2006; 43(12):1612-5. doi: 10.1086/508865 PMID: 17109297.
28. Ministry of Health. Chronic Disease Risk Factor Surveillance Report. Gaborone, Botswana: 2010.
29. Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 2013; 208(3):454-62. doi: 10.1093/infdis/jit181 PMID: 23624362.
30. Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009; 113(1):26-31. doi: 10.1097/AOG.0b013e31819225cb PMID: 19104356.